Biotechnology
Pfizer’s RSV vaccine shows potential to protect high-risk adults ages 18-59, widening possible use
Respiratory syncytial virus – viral vaccine under research Hailshadow | Istock | Getty Images A vaccine from Pfizer showed the potential to protect adults ages 18 to 59 who are at increased risk of getting severely sick from respiratory syncytial virus in a late stage clinical trial, the company said Tuesday. The initial data suggests […]
Read More
Many CVS drug plans will cover over-the-counter birth control pill at no cost
In this photo illustration, a package of Opill is displayed on March 22, 2024 in San Anselmo, California. Justin Sullivan | Getty Images CVS Health on Thursday said its drug plans will cover the first over-the-counter birth control pill in the U.S. at no cost for many health plan sponsors, a decision that could open […]
Read More
Diabetes drug similar to Ozempic helped slow progression of Parkinson's disease in small trial
The coronal view of a human brain of a patient suffering from Parkinson’s disease Sherbrooke Connectivity Imaging Lab | Getty Images A highly popular class of drugs for diabetes and obesity is showing early potential to help patients with Parkinson’s disease, too. An older diabetes treatment called lixisenatide helped slow the progression of motor disability […]
Read More
Health insurer stocks slide as final Medicare Advantage rates disappoint
Signage is displayed on a Humana Inc. office building in Louisville, Kentucky, U.S., on Saturday, Feb. 2, 2019. Humana is scheduled to release earnings figures on February 6. Luke Sharrett | Bloomberg | Getty Images Shares of U.S. health insurers fell on Tuesday after the Biden administration didn’t boost payments for private Medicare plans as […]
Read More
Walgreens tops quarterly revenue estimates, but narrows profit outlook in 'challenging' economy
A person rides past a Walgreens truck, owned by the Walgreens Boots Alliance, Inc., in Manhattan, New York City, U.S., November 26, 2021. Andrew Kelly | Reuters Walgreens on Thursday reported fiscal second-quarter sales that beat Wall Street’s expectations, but lowered the high end of its full-year adjusted earnings outlook in part due to a […]
Read More
Altimmune says weight loss drug minimized muscle loss in trial results, which may set it apart
Altimmune on Wednesday said its experimental drug helped patients shed weight but also minimized the loss of muscle mass in a midstage trial, a finding that could set it apart in a potentially crowded market. Altimmune is one of several smaller biotech companies that are pushing to compete directly with Novo Nordisk and Eli Lilly […]
Read More
Novo Nordisk's $1,000 diabetes drug Ozempic can be made for less than $5 a month, study suggests
A box of Ozempic and contents sit on a table in Dudley, North Tyneside, Britain, October 31, 2023. Lee Smith | Reuters The blockbuster diabetes drug Ozempic could be manufactured for less than $5 a month, even as Novo Nordisk charges close to $1,000 per month for the injection in the U.S. before insurance, a […]
Read More
Moderna moves three vaccines into final stage trials as it works to rebound from Covid slump
Nikos Pekiaridis | Lightrocket | Getty Images Moderna has more to offer beyond its Covid vaccine. The biotech company made that clear on Wednesday, announcing positive clinical trial data on three experimental vaccines for other diseases. The company is moving those shots to final stage studies, it said. The update brings Moderna a step closer […]
Read More
Fda approves Merck's drug for exceptional, deadly lung ailment
The Foods and Drug Administration on Tuesday accredited a drug from Merck created to handle a progressive and existence-threatening lung situation in a earn for each the drugmaker and for patients suffering from the uncommon illness. The company greenlighted the therapy, which will be marketed as Winrevair, for older people with pulmonary arterial hypertension. The […]
Read More
Moderna says new Covid vaccine showed stronger immune response than current shot in study
A nurse fills a syringe with Moderna Covid-19 vaccine. Fred Tanneau | Afp | Getty Images Moderna on Tuesday said a new version of its Covid vaccine triggered a stronger immune response against the virus than its current shot in a late-stage trial. The results come as Moderna competes with rival Pfizer for more share […]
Read More